I, guinea pig
Why I signed up for a COVID vaccine trial.
I’ve finally had my first dose of a COVID-19 vaccine. Maybe.
What a face, huh?
Nova Scotia has picked up its vaccination pace in recent weeks, and I’m old enough to qualify for the Pfizer or Moderna vaccine (or the AstraZeneca one, if it’s reintroduced; no sign of the one-and-done Johnson & Johnson shot here yet). Naturally, I decided to go with…a Phase 1/Phase 2 trial of a new vaccine which hasn’t been officially approved yet.
The first volunteers have been selected for a vaccine trial of COVAC-2, a COVID-19 vaccine developed by the Vaccine and infectious Disease Organization (VIDO) at the University of Saskatchewan (USask).
“We are excited to start clinical trials,” said VIDO Director Dr. Volker Gerdts. “Our team has worked hard to advance the development of this vaccine to help combat the COVID-19 pandemic.”
The trial was designed as a combined Phase 1/Phase 2 study. Phase 1 will vaccinate 108 healthy volunteers in a placebo-controlled study at the Canadian Center for Vaccinology (…
Keep reading with a 7-day free trial
Subscribe to Rigid Thinking to keep reading this post and get 7 days of free access to the full post archives.